Prophylactic Photodynamic Therapy to Organ Transplant Patients

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind

Related Conditions & MeSH terms

Organ Transplants

See also
Status	Clinical Trial	Phase
Completed	`NCT01070901` - Immune Status in Solid Organ Transplantation	N/A
Completed	`NCT02676102` - RCT Comparing Tailored Versus Targeted Organ Donation Video Education	N/A
Completed	`NCT03525210` - Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients	Phase 3
Completed	`NCT05189340` - Development of Discharge Education Video for Solid Organ Transplant Recipients	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01070901 - Immune Status in Solid Organ Transplantation

N/A

Completed

NCT02676102 - RCT Comparing Tailored Versus Targeted Organ Donation Video Education

N/A

Completed

NCT03525210 - Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients

Phase 3

Completed

NCT05189340 - Development of Discharge Education Video for Solid Organ Transplant Recipients

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00365521
Study type	Interventional
Source	Bispebjerg Hospital
Contact	Merete Hædersdal, MD, PhD, DrMedSci
Phone	+45 35316002
Email	mhaedersdal@dadlnet.dk
Status	Not yet recruiting
Phase	N/A
Start date	April 2009

Prophylactic Photodynamic Therapy to Organ Transplant Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms